Boston Scientific Receives CE Mark for Next Generation WATCHMAN FLX(TM) Left Atrial Appendage Closure Device

Company begins limited market release in Europe MARLBOROUGH, Mass., March 13, 2019 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) announced it has received CE Mark and initiated a limited market release of the ne... Devices, Interventional, Cardiology, Regulatory Boston Scientific, WATCHMAN, WATCHMAN FLX, Left Atrial Appendage Closure
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news